Clinical trial
Gut Microbiome and Oral Fluoropyrimidine Study in Patients With Colorectal Cancer
NCT04054908 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gut Microbiome and Oral Fluoropyrimidine Study in Patients With Colorectal Cancer
- Lead sponsor
- University of California, San Francisco
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 13, 2018
- Completion date
- June 30, 2022
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal microbiome, neoplasm, colorectal